Both medical and technological developments have led to the increased provision of cancer medicines on the market, making it possible for cancer patients to live longer with a better quality of life. However, currently, the only way to bring innovative therapies to patients is via a commercial route, with extremely high prices.

With this event, we want to shine a light on the role that academia can play in the development and availability of innovative cell and gene therapies. We will also engage panellists representing the European Commission, the European Medicines Agency, researchers, and patients in a discussion on the main bottlenecks that hinder such pathways of medicines development and how to overcome them.

The online event will take place on 29 March 2023, 15:00-16:30 (CEST).